SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-294747
Filing Date
2020-11-16
Accepted
2020-11-16 16:05:51
Documents
3
Period of Report
2020-11-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d45518d8k.htm 8-K 19134
2 EX-99.1 d45518dex991.htm EX-99.1 49592
3 GRAPHIC g45518g1113224916431.jpg GRAPHIC 4234
  Complete submission text file 0001193125-20-294747.txt   75969
Mailing Address 134 COOLIDGE AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 134 COOLIDGE AVENUE 2ND FLOOR WATERTOWN MA 02472 617-393-5925
Pandion Therapeutics, Inc. (Filer) CIK: 0001807901 (see all company filings)

IRS No.: 833015614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39381 | Film No.: 201316768
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences